Pfizer Us Pharmaceutical Group
Pfizer Us Pharmaceutical Group appears in FDA public data with 4 recalls — including 1 Class I (most serious) —, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-1409-2014, Class II) was initiated on April 16, 2014.
Summary
- Total Recalls
- 4 (1 Class I)
- 510(k) Clearances
- 0
- Inspections
- 0
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-1409-2014 | Class II | Pristiq (desvenlafaxine) Extended-Release Tablets 50 mg, 30 count bottle, Rx only, Distributed by Wy | April 16, 2014 |
| D-1328-2014 | Class I | Effexor XR (venlafaxine HCl) Extended-Release Capsules, 150 mg, packaged in a) 30-count Unit of Use | March 6, 2014 |
| D-1166-2014 | Class III | Advil PM Caplets, (Ibuprofen, 200 mg /Diphenhydramine citrate, 38 mg) 120 count bottle, OTC, Pfizer, | February 26, 2014 |
| D-014-2014 | Class II | Aldactone (spironolactone) tablets, USP, 100 mg, 100-count bottles, Rx only, Distributed by G.D. Sea | September 4, 2013 |